MLchartDataset catalogue

tetanus peptide melanoma vaccine

Term · Oncology and biomedicine · MLC-T-ONC-017085

A vaccine consisting of peptides derived from melanoma-associated antigens and a modified T-cell epitope derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic and helper T-cell response against tumor cells expressing melanoma-associated antigens, resulting in decreased tumor growth.

Table 1. Record
IdentifierMLC-T-ONC-017085
FieldOncology and biomedicine
AbbreviationTet p
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017085",
  "term": "tetanus peptide melanoma vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A vaccine consisting of peptides derived from melanoma-associated antigens and a modified T-cell epitope derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic and helper T-cell response against tumor cells expressing melanoma-associated antigens, resulting in decreased tumor growth.",
  "abbreviation": "Tet p",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/tetanus-peptide-melanoma-vaccine/"
}

Record 16,193 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.